← Leaderboards
Elizabeth Marjorie Cespedes Feliciano
Columbia University Health Sciences
$11,082,667
Attributed
$13,758,753
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.2M · FY2018–25$5M$3.8M$2.5M$1.3M$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,260,289 · 6
FDA$1,498,464 · 1
By mechanism
R01$11,365,813 · 5
U01$1,498,464 · 1
K01$894,476 · 1
Top collaborators
- Alexandra Margaret Lynn Binder3 shared
- Adana A. M. Llanos2 shared
- Andrew Patrick Ambrosy1 shared
- David Ouyang1 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Rudolph L Leibel$35,102,760
- Wendy K Chung$27,581,365
- Streamson C Chua$14,705,494
- Adana A. M. Llanos$3,158,896
- Nour Makarem$4,498,776
Others in their field
Other Emerging Leaders on “Mortality”
- Chanza Baytop · Westat, Inc.$271,217,917
- Beth Baseler · Leidos Biomedical Research, Inc.$87,027,148
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$56,084,949
- Greg Witham · Anp Technologies, Inc.$19,727,817
- Yunda Huang · Fred Hutchinson Cancer Center$19,033,873
- Barbara Halina Braffett · George Washington University$17,931,151
Research focus
MortalityFutureMuscleMalignant NeoplasmsCohortMuscle FormBreast Cancer PatientMalignant Breast NeoplasmX-Ray Computed TomographyPhenotypeScanningCancer PatientBiological MarkersObesityMuscular AtrophyTumorBody CompositionSamplingSkeletal MuscleAdipose TissueAffectSurgical ComplicationComputerized Medical RecordCessation Of Life
Grant awards (27)
AI-Enabled Echocardiographic Biomarkers and Real-World Data for Predicting Cancer Therapy-Related Cardiac Dysfunction$1,498,464
U01 · FY2025 · FD · contact PI
Long-Term Trajectories of Accelerated Biological Aging and Functional Decline Associated with Breast Cancer and its Treatment$667,754
R01 · FY2025 · CA · contact PI
Body composition and breast cancer survival: immune and metabolic biomarkers in breast tumors$492,813
R01 · FY2025 · CA · contact PI
Understanding the role of adiposity and adipokine-related RNA expression in the tumor microenvironment on breast cancer outcomes in a racially and ethnically diverse sample$671,015
R01 · FY2024 · CA
Long-Term Trajectories of Accelerated Biological Aging and Functional Decline Associated with Breast Cancer and its Treatment$623,178
R01 · FY2024 · CA · contact PI
Informatics approaches to assessing patient frailty in surgical care$558,443
R01 · FY2024 · AG · contact PI
Body composition and breast cancer survival: immune and metabolic biomarkers in breast tumors$100,924
R01 · FY2024 · CA · contact PI
Understanding the role of adiposity and adipokine-related RNA expression in the tumor microenvironment on breast cancer outcomes in a racially and ethnically diverse sample$735,278
R01 · FY2023 · CA
Long-Term Trajectories of Accelerated Biological Aging and Functional Decline Associated with Breast Cancer and its Treatment$656,996
R01 · FY2023 · CA · contact PI
Body composition and breast cancer survival: immune and metabolic biomarkers in breast tumors$629,131
R01 · FY2023 · CA · contact PI
Informatics approaches to assessing patient frailty in surgical care$588,470
R01 · FY2023 · AG · contact PI
D3-creatine dilution to determine skeletal muscle mass in colon cancer patients$380,025
R01 · FY2023 · CA · contact PI
Body composition and breast cancer survival: immune and metabolic biomarkers in breast tumors - Disparities Supplement$230,018
R01 · FY2023 · CA · contact PI
Body composition and breast cancer survival: immune and metabolic biomarkers in breast tumors$650,996
R01 · FY2022 · CA · contact PI
Informatics approaches to assessing patient frailty in surgical care$607,006
R01 · FY2022 · AG · contact PI
D3-creatine dilution to determine skeletal muscle mass in colon cancer patients$379,209
R01 · FY2022 · CA · contact PI
Beyond Body Mass Index: Bringing Body Composition into Oncology Practice$179,411
K01 · FY2022 · CA · contact PI
Body composition and breast cancer survival: immune and metabolic biomarkers in breast tumors$696,446
R01 · FY2021 · CA · contact PI
Informatics approaches to assessing patient frailty in surgical care$611,230
R01 · FY2021 · AG · contact PI
D3-creatine dilution to determine skeletal muscle mass in colon cancer patients$377,538
R01 · FY2021 · CA · contact PI
Beyond Body Mass Index: Bringing Body Composition into Oncology Practice$179,303
K01 · FY2021 · CA · contact PI
Body composition and breast cancer survival: immune and metabolic biomarkers in breast tumors$699,075
R01 · FY2020 · CA · contact PI
Informatics approaches to assessing patient frailty in surgical care$629,037
R01 · FY2020 · AG · contact PI
D3-creatine dilution to determine skeletal muscle mass in colon cancer patients$381,231
R01 · FY2020 · CA · contact PI
Beyond Body Mass Index: Bringing Body Composition into Oncology Practice$178,446
K01 · FY2020 · CA · contact PI
Beyond Body Mass Index: Bringing Body Composition into Oncology Practice$178,686
K01 · FY2019 · CA · contact PI
Beyond Body Mass Index: Bringing Body Composition into Oncology Practice$178,630
K01 · FY2018 · CA · contact PI